Answer
In 22 previously treated adults aged ≥19 years with severe haemophilia B, Alprolix (eftrenonacog alfa) had a geometric mean elimination half-life of 82.12 hours (95% CI 71.39–94.46) by compartmental analysis after a single 50 IU/kg dose.
Sources for this answer
- ALPROLIX 250 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 9Document updated
Sources checked